Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.8%

1 terminated out of 57 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

36%

4 of 11 completed with results

Key Signals

4 with results92% success

Data Visualizations

Phase Distribution

39Total
Not Applicable (20)
Early P 1 (1)
P 1 (8)
P 2 (10)

Trial Status

Recruiting20
Not Yet Recruiting12
Completed11
Unknown8
Active Not Recruiting2
Enrolling By Invitation2

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (57)

Showing 20 of 20 trials
NCT07737977Not Yet RecruitingPrimary

Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients

NCT07047209Phase 2CompletedPrimary

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

NCT07400393Not Yet Recruiting

Healey ALS MyMatch Common Screening Protocol

NCT07088159UnknownPrimary

Intermediate-size Patient Population Expanded Access Protocol

NCT07698496Not ApplicableNot Yet Recruiting

Evaluation of the Feasibility and Efficacy of a Chronic Brain-computer Interface for Speech Rehabilitation in Patients With Locked-in-syndrome (LIS)

NCT07688239Phase 2Not Yet Recruiting

The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

NCT07680361Not ApplicableCompleted

Study of Home Use of the Jaco Robotic Manipulation Device by Individuals With Tetraplegia

NCT06051123Not ApplicableRecruiting

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

NCT07294144Phase 2RecruitingPrimary

Tofersen in Non-SOD1 ALS

NCT03241784Phase 1CompletedPrimary

Ph1 T-Regulatory Cells in Amyotrophic Lateral Sclerosis

NCT07618585Phase 1Active Not Recruiting

Safety and Efficacy of Intrathecal NTF001 Injection in ALS

NCT07595666Not ApplicableEnrolling By Invitation

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

NCT07543367Not ApplicableRecruiting

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

NCT07295990Not ApplicableRecruiting

Tongue-strengthening Exercises in People With ALS.

NCT06782724Phase 2Recruiting

Psilocybin Therapy for Psychological Distress in Palliative Patients

NCT07407725Not ApplicableRecruiting

Clinical Outcome Assessment for AT & BCI

NCT07467187Recruiting

Invasive Home Ventilation in Denmark

NCT07539662Not ApplicableEnrolling By InvitationPrimary

Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT06856850RecruitingPrimary

Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

NCT07491562Not ApplicableRecruitingPrimary

Evaluation of a Structurally Suitable Neck Exoskeleton in Patients With Amyotrophic Lateral Sclerosis

Scroll to load more

Research Network

Activity Timeline